Hint mode is switched on Switch off
For swift navigation between sections

Argenx
LEI 7245009C5FZE6G9ODQ71

Organization name
Argenx S.E.
Country name
Netherlands
Country of registration
Netherlands
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Argenx S.E., a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer.

Awards

Documentation

IFRS/US GAAP reports

2025
2024
2023
2022
2021
2020
2019
2018
2017
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • LEI
    7245009C5FZE6G9ODQ71
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001697862
Registration is required to get access.